• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群、短链脂肪酸与草药

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines.

作者信息

Feng Wuwen, Ao Hui, Peng Cheng

机构信息

School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Pharmacol. 2018 Nov 23;9:1354. doi: 10.3389/fphar.2018.01354. eCollection 2018.

DOI:10.3389/fphar.2018.01354
PMID:30532706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6265305/
Abstract

As an important source for traditional medical systems such as Ayurvedic medicine and traditional Chinese medicine, herbal medicines have received widespread attentions from all over the world, especially in developing countries. Over the past decade, studies on gut microbiota have generated rich information for understanding how gut microbiota shape the functioning of our body system. In view of the importance of gut microbiota, the researchers engaged in studying herbal medicines have paid more and more attention to gut microbiota and gut microbiota metabolites. Among a variety of gut microbiota metabolites, short-chain fatty acids (SCFAs) have received most attention because of their important role in maintaining the hemostasis of hosts and recovery of diseases. Herbal medicines, as an important resource provider for production of SCFAs, have been demonstrated to be able to modulate gut microbiota composition and regulate SCFAs production. In this mini-review, we summarize current knowledge about SCFAs origination, the role of SCFAs in health and disease, the influence of herbal medicine on SCFAs production and the corresponding mechanisms. At the end of this review, the strategies and suggestions for further research of SCFAs and herbal medicines are also discussed.

摘要

作为阿育吠陀医学和传统中医等传统医学体系的重要来源,草药受到了全世界尤其是发展中国家的广泛关注。在过去十年中,关于肠道微生物群的研究为理解肠道微生物群如何塑造我们身体系统的功能提供了丰富信息。鉴于肠道微生物群的重要性,从事草药研究的人员越来越关注肠道微生物群及其代谢产物。在各种肠道微生物群代谢产物中,短链脂肪酸(SCFAs)因其在维持宿主内环境稳定和疾病康复中的重要作用而受到最多关注。草药作为SCFAs产生的重要资源提供者,已被证明能够调节肠道微生物群组成并调节SCFAs的产生。在本综述中,我们总结了关于SCFAs的产生、SCFAs在健康和疾病中的作用、草药对SCFAs产生的影响及其相应机制的现有知识。在本综述结尾,还讨论了SCFAs和草药进一步研究的策略和建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afd/6265305/3370c8549c15/fphar-09-01354-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afd/6265305/3370c8549c15/fphar-09-01354-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7afd/6265305/3370c8549c15/fphar-09-01354-g0001.jpg

相似文献

1
Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines.肠道微生物群、短链脂肪酸与草药
Front Pharmacol. 2018 Nov 23;9:1354. doi: 10.3389/fphar.2018.01354. eCollection 2018.
2
Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus.肠道微生物群,中药治疗糖尿病的潜在新靶点。
Evid Based Complement Alternat Med. 2019 Feb 18;2019:2634898. doi: 10.1155/2019/2634898. eCollection 2019.
3
Gut microbiota, a new frontier to understand traditional Chinese medicines.肠道微生物群,理解中药的新前沿。
Pharmacol Res. 2019 Apr;142:176-191. doi: 10.1016/j.phrs.2019.02.024. Epub 2019 Feb 25.
4
Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.黄芩和黄连通过调节肠道微生物群及其代谢物改善 2 型糖尿病大鼠的糖脂代谢。
Appl Microbiol Biotechnol. 2020 Jan;104(1):303-317. doi: 10.1007/s00253-019-10174-w. Epub 2019 Nov 22.
5
Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.短链脂肪酸:缓解应激诱导的脑肠轴改变的微生物代谢产物。
J Physiol. 2018 Oct;596(20):4923-4944. doi: 10.1113/JP276431. Epub 2018 Aug 28.
6
The interplay between herbal medicines and gut microbiota in metabolic diseases.草药与肠道微生物群在代谢性疾病中的相互作用。
Front Pharmacol. 2023 Mar 24;14:1105405. doi: 10.3389/fphar.2023.1105405. eCollection 2023.
7
Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids.肠道微生物群、饮食摄入与血清短链脂肪酸和粪便短链脂肪酸之间的关联。
Biosci Microbiota Food Health. 2020;39(1):11-17. doi: 10.12938/bmfh.19-010. Epub 2019 Oct 5.
8
Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.通过调节肠道菌群平衡草药与功能性食品以预防和治疗心脏代谢疾病
Front Microbiol. 2017 Nov 8;8:2146. doi: 10.3389/fmicb.2017.02146. eCollection 2017.
9
Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids.葛根芩连汤通过调节肠道微生物群和短链脂肪酸治疗仔猪腹泻。
Front Microbiol. 2019 Apr 18;10:825. doi: 10.3389/fmicb.2019.00825. eCollection 2019.
10
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.短链脂肪酸:传统医学治疗炎症性肠病的重要武器。
Molecules. 2024 Jan 12;29(2):379. doi: 10.3390/molecules29020379.

引用本文的文献

1
From gut microbial ecology to lipid homeostasis: Decoding the role of gut microbiota in dyslipidemia pathogenesis and intervention.从肠道微生物生态到脂质稳态:解读肠道微生物群在血脂异常发病机制及干预中的作用
World J Gastroenterol. 2025 Aug 14;31(30):108680. doi: 10.3748/wjg.v31.i30.108680.
2
Faecal microbiota differences between an autochthonous pig breed and a commercial line.一个本地猪种和一个商业品系之间的粪便微生物群差异。
Sci Rep. 2025 Sep 1;15(1):32176. doi: 10.1038/s41598-025-13460-y.
3
A Review of Modulation of Gut Microbiota to Mitigate Gestational Diabetes: Implications for Maternal and Child Health.

本文引用的文献

1
Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway.柴胡疏肝散通过NLRP3炎性小体途径调节非酒精性脂肪性肝病大鼠肠道微生物群失调并减轻慢性代谢性炎症
Evid Based Complement Alternat Med. 2018 Jul 11;2018:9390786. doi: 10.1155/2018/9390786. eCollection 2018.
2
Gut commensal plays a predominant role in the anti-obesity effects of polysaccharides isolated from .肠道共生菌在 中分离得到的多糖的抗肥胖作用中起主要作用。
Gut. 2019 Feb;68(2):248-262. doi: 10.1136/gutjnl-2017-315458. Epub 2018 Jul 14.
3
Communication Between the Microbiota and Mammalian Immunity.
调节肠道微生物群以减轻妊娠期糖尿病的综述:对母婴健康的影响
Med Sci Monit. 2025 Aug 22;31:e948897. doi: 10.12659/MSM.948897.
4
Temporal Dynamics of Fecal Microbiome and Short-Chain Fatty Acids in Sows from Early Pregnancy to Weaning.从妊娠早期到断奶期母猪粪便微生物群和短链脂肪酸的时间动态变化
Animals (Basel). 2025 Jul 27;15(15):2209. doi: 10.3390/ani15152209.
5
Bridging traditional Chinese medicine and Alzheimer's disease: the pivotal role of gut microbiota in multitarget therapeutic mechanisms.中医与阿尔茨海默病的桥梁:肠道微生物群在多靶点治疗机制中的关键作用
Front Pharmacol. 2025 Jun 27;16:1630205. doi: 10.3389/fphar.2025.1630205. eCollection 2025.
6
Exploring the Potential of Novel Animal-Origin Probiotics as Key Players in One Health: Opportunities and Challenges.探索新型动物源益生菌作为“同一健康”关键参与者的潜力:机遇与挑战。
Int J Mol Sci. 2025 May 27;26(11):5143. doi: 10.3390/ijms26115143.
7
Polygoni Multiflori Radix Praeparata polysaccharides enhance gut health and mitigate ischemic stroke by regulating SCFA and amino acid metabolism in gut microbiota.制何首乌多糖通过调节肠道微生物群中的短链脂肪酸和氨基酸代谢来增强肠道健康并减轻缺血性中风。
Front Pharmacol. 2025 May 22;16:1580055. doi: 10.3389/fphar.2025.1580055. eCollection 2025.
8
Polyphenol-mediated microbiome modulation in STEMI patients: a pilot study.多酚介导的ST段抬高型心肌梗死患者微生物群调节:一项初步研究。
Front Med (Lausanne). 2025 May 21;12:1522373. doi: 10.3389/fmed.2025.1522373. eCollection 2025.
9
A Review of Next-Generation Probiotics-As a Gateway to Biotherapeutics.下一代益生菌——通向生物疗法的途径综述
Probiotics Antimicrob Proteins. 2025 Jun 3. doi: 10.1007/s12602-025-10606-2.
10
The role of intestinal microbiota and its metabolites in the occurrence and intervention of obesity.肠道微生物群及其代谢产物在肥胖发生与干预中的作用。
Front Microbiol. 2025 May 2;16:1559178. doi: 10.3389/fmicb.2025.1559178. eCollection 2025.
微生物群与哺乳动物免疫之间的交流。
Annu Rev Microbiol. 2018 Sep 8;72:399-422. doi: 10.1146/annurev-micro-090817-062307. Epub 2018 Jun 21.
4
Effects of a homogeneous polysaccharide from Sijunzi decoction on human intestinal microbes and short chain fatty acids in vitro.四君子汤均一多糖对体外人肠道微生物及短链脂肪酸的影响。
J Ethnopharmacol. 2018 Oct 5;224:465-473. doi: 10.1016/j.jep.2018.06.006. Epub 2018 Jun 15.
5
Ethanol extract of Ganoderma lucidum ameliorates lipid metabolic disorders and modulates the gut microbiota composition in high-fat diet fed rats.灵芝乙醇提取物改善高脂饮食喂养大鼠的脂代谢紊乱,并调节其肠道微生物组成。
Food Funct. 2018 Jun 20;9(6):3419-3431. doi: 10.1039/c8fo00836a.
6
Best practices for analysing microbiomes.微生物组分析的最佳实践。
Nat Rev Microbiol. 2018 Jul;16(7):410-422. doi: 10.1038/s41579-018-0029-9.
7
Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism.口服羟基红花黄色素A通过调节肠道微生物群和血清代谢减轻小鼠肥胖。
Pharmacol Res. 2018 Aug;134:40-50. doi: 10.1016/j.phrs.2018.05.012. Epub 2018 May 19.
8
Carboxymethyl pachyman (CMP) reduces intestinal mucositis and regulates the intestinal microflora in 5-fluorouracil-treated CT26 tumour-bearing mice.羧甲基茯苓多糖(CMP)可减轻 5-氟尿嘧啶处理的 CT26 荷瘤小鼠的肠道黏膜炎,并调节肠道微生物群。
Food Funct. 2018 May 23;9(5):2695-2704. doi: 10.1039/c7fo01886j.
9
Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota.薜辛糖通过调节肠道微生物群改善 2 型糖尿病大鼠的症状。
Sci Rep. 2018 Feb 27;8(1):3685. doi: 10.1038/s41598-018-22094-2.
10
Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.人参多糖通过增强肠道吸收和影响肠道微生物代谢来增强人参皂苷 Rb1 和微生物代谢物的暴露。
J Ethnopharmacol. 2018 Apr 24;216:47-56. doi: 10.1016/j.jep.2018.01.021. Epub 2018 Jan 31.